October 14, 2009
ASKLEP Inc. to exhibit at DIA Japan Oct 22-23, 2009
ASKLEP Inc. (Japan) will be exhibiting at The 6th Annual Japan DIA Meeting to be held in Tokyo. DIA Japan conference focuses on Clinical Development in an Era of Globalization.
Harrison Clinical Research (Europe), ASKA Research (Canada), DreamCIS (Korea) and Qualitix Clinical Research (Taiwan) are ASKLEP's global CRO partners along with XClinical, an EDC provider. Our network of CROs allows our clients access to strategic markets around the globe where our partners provide quality CRO services.
To learn more about us and our global partners, we welcome you to drop by our booth in the exhibition area anytime. A representative from Harrison Clinical Research will be in attendance to answer any questions.
The 6th Annual Japan DIA Meeting
TowerHallFunabori(Tokyo, Japan) ＜MAP＞
October 22－23, 2009
ASKLEP Booth ＃8
About ASKLEP
Asklep, Inc., (http://www.asklep.co.jp) founded in 1992, in Tokyo, Japan, provides clinical research services in monitoring, data management, biostatistics, regulatory & consulting, CRA training, etc. ASKLEP with over 300 professionals located in Tokyo and Osaka, offers high quality clinical research services to pharmaceutical, biotech and device companies. ASKLEP is an INTAGE Group Company (www.intage.co.jp)
About Harrison Clinical Research Group
Harrison Clinical Research Group (http://www.harrisonclinical.com/), is a Munich, Germany based CRO with 11 offices throughout Europe, and a state-of-the-art Phase I facility in Munich. Harrison offers the full-range of services required for the clinical development and registration of new pharmaceutical products and medical devices, from single studies to complete development programs. The international project management and monitoring teams perform Phase I - IV studies either locally or globally, as required. HCR was established in 1987 and is ISO9001:2000 compliant.
About ASKA Research
ASKA Research (http://www.askaresearch.com/), is a Vancouver, Canada based CRO who manage and monitor all facets of regional, national and North American clinical trials. ASKA Research provides a full range of multi-center clinical trial management and monitoring services from project conception to marketing approval. ASKA Research, a Division of Valerie Willetts & Associates Inc., was founded in 1995.
About Dream CIS
With abundant experience and know-how, DreamCIS (www.dreamcis.com) helps pharmaceutical, biotech and device manufacturers plan and manage trials from beginning to end. DreamCIS strengths are study consulting and study design, medical writing and feasibility for patient recruitment along with subsequent clinical monitoring. DreamCIS provides clinical trial services, either for an entire project or certain stages of a project, that meet client needs, in accordance with KGCP, GCP and ICH guidelines. Since the company established in 2000, DreamCIS has conducted 255 clinical trials in Phase I to IV, and over 480 projects in Pharmacovigilance and Post-Marketing Surveillance.
About Qualitix Clinical Research
Qualitix Clinical Research Co., Ltd.(http://www.qualitix.com.tw/) Qualitix is a full service CRO based in Taiwan and focuses on clinical monitoring and site management services for multinational phase II and phase III studies. Qualitix was established in June 2008; however, CRO business was commenced since 1997 under its parent company Genovate Biotechnology Co., Ltd. (http://www.genovate-bio.com/) Qualitix plans to establish its presence in China by end of 2009 and expand its service area to China.
About XClinical
XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM). Till today, MARVIN was used to collect and process data of more than 50,000 patients in 50+ studies.
Contact: ASKLEP Corporate Planning and Development Dept. Tel: 81-3-5294-5223
